HealthEquity (HQY) Projected to Post Quarterly Earnings on Tuesday

HealthEquity (NASDAQ:HQY) will likely be issuing its Q1 2026 quarterly earnings data before the market opens on Tuesday, June 3rd. Analysts expect the company to announce earnings of $0.81 per share and revenue of $322.25 million for the quarter.

HealthEquity Stock Performance

Shares of HQY opened at $99.01 on Tuesday. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The firm has a fifty day simple moving average of $88.32 and a 200 day simple moving average of $97.40. The stock has a market capitalization of $8.56 billion, a price-to-earnings ratio of 90.83, a PEG ratio of 1.60 and a beta of 0.45. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

Analysts Set New Price Targets

Several analysts have issued reports on HQY shares. Barrington Research reaffirmed an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. KeyCorp dropped their price target on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 16th. Wells Fargo & Company upped their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Royal Bank of Canada started coverage on shares of HealthEquity in a research report on Thursday, May 22nd. They set an “outperform” rating and a $112.00 price target on the stock. Finally, Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and dropped their price target for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $112.33.

Insider Activity

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now directly owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.